Search for: "Novartis Pharmaceuticals Inc"
Results 301 - 320
of 394
Sorted by Relevance
|
Sort by Date
18 Mar 2016, 2:04 pm
Novartis Pharmaceuticals Corp., No. [read post]
25 May 2015, 4:15 am
******************PREVIOUSLY, ON NEVER TOO LATENever too late 46 [week ending on Sunday 17 May] – Whyte & MacKay Ltd v Origin Wine UK Ltd and Dolce Co Invest Inc | "Three aspects of information: Current issues in trade secrets, client confidentiality and privilege" -- a new event | CJEU upon distribution right in Dimensione Direct Sales srl and Michele Labianca v Knoll International SpA| UK Supreme Court on Mere reputation and passing-off |… [read post]
23 Aug 2016, 10:34 am
” Appellee Br.at 7 n.3 (citing Novartis Pharmaceuticals Corp. v. [read post]
7 Aug 2014, 5:00 am
Novartis Pharmaceuticals Corp., 2014 WL 3735622 (E.D. [read post]
18 May 2015, 11:01 am
******************PREVIOUSLY, ON NEVER TOO LATENever too late 45 [week ending on Sunday 10 May] – INTA 2015 and the Kat | IP and Competition Law | Sky v Skype | CJEU v Spain | Digital Single Market Strategy | IPCom v HTC | European Qualifying Examination appealed | UPC fees | CJEU and 3-D marks | EPO Oral Proceedings.Never too late 44 [week ending on Sunday 3 May] – Forgotten principles and histories, and the role of complexity in patent law… [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
6 Oct 2010, 11:43 pm
Novartis Pharms. [read post]
22 Dec 2010, 3:23 pm
The Food & Drug Administration’s citation of Novartis for Facebook content that lacked required pharmaceutical side-effect warnings and disclaimers, and the agency’s subsequent delay in release of social media “guidance” for pharma until Q1 2011. [read post]
19 Apr 2011, 10:01 am
Novartis Pharmaceuticals, Inc., 06 Civ. 0260 (BMC) (RER), slip op. [read post]
22 Apr 2012, 12:08 pm
Novartis Pharmaceuticals Corp.pdf (Nos. 09-6147/6272/6274) (discussed further here). [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
22 Apr 2012, 12:08 pm
Novartis Pharmaceuticals Corp.pdf (Nos. 09-6147/6272/6274) (discussed further here). [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter… [read post]
15 Jan 2018, 11:40 am
Supreme Court rulings: Pliva Inc. v. [read post]
29 Dec 2011, 6:53 am
Wyeth Pharmaceuticals, 797 F. [read post]
24 Dec 2014, 5:00 am
Novartis Pharmaceutical Corp., 767 F.3d 526 (6th Cir. 2014). [read post]
22 Sep 2022, 9:54 am
AbbVie Inc, 7th U.S. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
22 Mar 2010, 4:13 am
Novartis Pharmaceuticals Corp., 564 F. [read post]
24 Aug 2015, 5:00 am
Abbott Laboratories, Inc., ___ F. [read post]
